Dorset Lung Cancer Pathway is boosted by CT system to fast-track lung cancer referrals

Poole Hospital NHS Foundation Trust has installed an Aquilion Prime SP CT scanner from Canon Medical Systems UK, as part of the Dorset Lung Cancer Pathway. It will enable greater imaging capacity to fulfil high priority fast-track lung cancer appointments across Dorset, taking patient referrals from the Poole catchment area, as well as from Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust and Dorset County Hospital NHS Foundation Trust.

The Poole Hospital site was selected for the additional lung cancer referral CT system as it is geographically central to the neighbouring trusts. The increased imaging capacity will help to deliver CT scans of patients with high suspicion chest x-rays within 72 hours, and reporting within three days. The system was selected for its high imaging speeds and to give continuity across the three hospitals, as reporting of patient diagnostic images takes place at the originating referral hospital. Outside of lung cancer referral work, it will be used for general imaging requirements.

“We have been delighted with the speed of imaging from the Aquilion Prime SP CT and its ease of use,” said Poole Hospital NHS Foundation Trust lead CT radiographer Amy Morris. “It will provide ‘bread and butter’ surveillance and staging scans, the vital part of lung cancer diagnosis and treatment planning in our county.”

Canon Medical Systems UK CT modality manager Mark Thomas said: “We look forward to supporting the Dorset scanner and ensuring the imaging team has all the necessary user skills to maximise productivity and patient workflow.”

Picture: Seated are Canon Medical UK account manager Iain Burley and deputy CT superintendent Katy Bysh. Behind them are CT radiographer Jesus Rengalota, care support workers Gabrielle Miles and Darren Brooke and CT radiographer Cliodhna Brennan.

Published on page 16 of the July 2020 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more